Sumitomo Pharma Co. Ltd. (DNPUF)

PNK: DNPUF · Real-Time Price · USD

5.80

1.70 (41.46%)

At close: May 01, 2025, 9:30 AM

Sumitomo Pharma Cash Flow Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Net Income	-314.93B	-96.71B	40.6B	36.83B	35.92B	48.63B	53.45B	47.22B	39.56B
Depreciation & Amortization	37.77B	41.26B	38.35B	22.67B	17.36B	13.98B	12.89B	18.62B	20.27B
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-125.36B	-26.22B	-4.32B	76.5B	-5.37B	3.88B	19.9B	15.99B	15.23B
Other Non-Cash Items	143.39B	32.51B	-13.98B	9.77B	13.7B	-69M	11.56B	-50.93B	-22.62B
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-108.11B	34.88B	-33.73B	66.33B	-20.85B	-13.82B	15.52B	6.72B	12.21B
Operating Cash Flow	-241.89B	11.94B	31.24B	135.6B	46.13B	48.71B	93.42B	21.62B	49.41B
Capital Expenditures	-15.73B	-12.74B	-13.49B	-10.81B	-13.35B	-12.91B	-12.35B	-13.46B	-9.74B
Cash Acquisitions	9.04B	30.17B	-3.7B	15.92B	-205.77B	1.69B	9.42B	-84.35B	-1.26B
Purchase of Investments	-4.77B	-6.25B	-25.91B	-9.37B	-112.49B	-2.78B	-6.23B	-356M	-297M
Sales Maturities Of Investments	34.5B	10.07B	19.47B	8.14B	1.62B	1.96B	31M	8.94B	24.88B
Other Investing Acitivies	10B	31.17B	5.35B	4.98B	17.31B	-23.01B	-7.4B	24.17B	-3.32B
Investing Cash Flow	33.04B	52.42B	-18.28B	8.88B	-312.68B	-35.05B	-16.52B	-59.73B	15.89B
Debt Repayment	84B	-20.06B	-4.96B	-24.03B	250.38B	-12.96B	-20.6B	-22B	-36.53B
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-2.79B	-11.13B	-11.13B	-11.12B	-13.11B	-11.12B	-7.94B	-7.15B	-7.15B
Other Financial Acitivies	-3.36B	-115.63B	-5.34B	-22.06B	-6.19B	-4.56B	-1.07B	39.03B	1.08B
Financial Cash Flow	77.85B	-146.82B	-21.43B	-57.22B	231.08B	-28.64B	-29.61B	9.88B	-42.6B
Net Cash Flow	-114.43B	-59.51B	9.29B	91.99B	-35.59B	-10.48B	42.17B	-29.97B	12.78B
Free Cash Flow	-257.62B	-805M	17.75B	124.8B	32.78B	35.8B	81.07B	8.16B	39.67B